Basilea Pharmaceutica AG 0QNA.L
0QNA.L
Basilea Pharmaceutica AG 0QOI.L
Newron Pharmaceuticals S.p.A. 0AAJ.L
PolyPeptide Group AG 0QXX.L
Molecular Partners AG 0QLX.L
Metall Zug AG 0QN1.L
Santhera Pharmaceuticals Holding AG 0RGI.L
Cosmo Pharmaceuticals N.V. 0RRB.L
DocMorris AG 0QKQ.L
Relief Therapeutics Holding AG 0QQM.L
IVF Hartmann Holding AG
Basilea Pharmaceutica AG 0QOI.L
Newron Pharmaceuticals S.p.A. 0AAJ.L
PolyPeptide Group AG 0QXX.L
Molecular Partners AG 0QLX.L
Metall Zug AG 0QN1.L
Santhera Pharmaceuticals Holding AG 0RGI.L
Cosmo Pharmaceuticals N.V. 0RRB.L
DocMorris AG 0QKQ.L
Relief Therapeutics Holding AG 0QQM.L
IVF Hartmann Holding AG
Performance
| Periode | 0QNA.L | 0QOI.L | 0AAJ.L | 0QXX.L | 0QLX.L | 0QN1.L | 0RGI.L | 0RRB.L | 0QKQ.L | 0QQM.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 19.68 % | 122.76 % | 40.19 % | -12.31 % | -20.80 % | -27.52 % | 50.76 % | -38.43 % | 14.05 % | -14.20 % |
| YTD | 17.51 % | 63.98 % | -19.35 % | -35.67 % | -31.43 % | -30.38 % | 7.32 % | -69.86 % | -36.11 % | -8.72 % |
| 1Y | 7.99 % | 60.88 % | -19.22 % | -47.42 % | -36.51 % | 14.19 % | -6.13 % | -80.41 % | -54.75 % | -3.55 % |
| 3Y | 10.05 % | 483.85 % | -6.36 % | -56.49 % | -57.73 % | 57.47 % | 34.33 % | -76.74 % | -73.96 % | 19.82 % |
| 5Y | 11.33 % | 738.90 % | -6.36 % | -81.20 % | -38.78 % | -65.70 % | -14.94 % | -98.30 % | -97.82 % | -15.00 % |
| 10Y | 11.33 % | -47.35 % | -6.36 % | -86.43 % | -81.03 % | -98.96 % | -60.40 % | -98.30 % | -97.82 % | -26.49 % |
| From the beginning | 11.33 % | -13.56 % | -6.36 % | -87.28 % | -81.03 % | -73.45 % | -60.40 % | -98.30 % | -97.82 % | -26.49 % |